
Day Two is a precision nutrition company leveraging microbiome data to provide personalized food recommendations for individuals with type 2 diabetes. Their innovative approach utilizes patented AI to predict blood sugar responses, enabling users to make informed dietary choices without restrictive diets. With over 80,000 members, Day Two collaborates with Fortune 500 companies and health systems, demonstrating significant outcomes such as an average drop in A1C of 1.1 and an average weight loss of 12 lbs. Their model focuses on empowering individuals through tailored nutrition plans and ongoing support from registered dietitians, positioning them as a leader in the precision health market.

Day Two is a precision nutrition company leveraging microbiome data to provide personalized food recommendations for individuals with type 2 diabetes. Their innovative approach utilizes patented AI to predict blood sugar responses, enabling users to make informed dietary choices without restrictive diets. With over 80,000 members, Day Two collaborates with Fortune 500 companies and health systems, demonstrating significant outcomes such as an average drop in A1C of 1.1 and an average weight loss of 12 lbs. Their model focuses on empowering individuals through tailored nutrition plans and ongoing support from registered dietitians, positioning them as a leader in the precision health market.
What they do: Precision nutrition using gut microbiome sequencing and ML to generate personalized food recommendations and a mobile app for blood-glucose, weight and metabolic health
Clinical outcomes: Reported average A1C drop of 1.1 and average weight loss of 12 lbs
Customers / partners: Consumers (test kit + app) and programs for health practitioners, Fortune 500 companies and health systems
Funding: Multiple rounds; most recent disclosed Series B on 2021-05-31; total disclosed funding ~$90.41M
Founders: Lihi Segal and Eran Segal (founding team includes additional named founders in some profiles)
Metabolic health, blood-glucose management, type 2 diabetes and weight management through personalized nutrition
Precision nutrition / healthtech
Most recent disclosed round per company profiles
“Poalim Equity; individual investors including Yair Schindel and Jacky Abitbol (Crunchbase lists ~18 investors)”